Form 8-K - Current report:
SEC Accession No. 0000950170-25-029021
Filing Date
2025-02-27
Accepted
2025-02-27 16:05:09
Documents
13
Period of Report
2025-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K orgo-20250227.htm   iXBRL 8-K 47687
2 EX-99.1 orgo-ex99_1.htm EX-99.1 857132
3 GRAPHIC img36819578_0.jpg GRAPHIC 10498
  Complete submission text file 0000950170-25-029021.txt   1074581

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT orgo-20250227.xsd EX-101.SCH 29653
15 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20250227_htm.xml XML 4518
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 25678634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)